Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels

scientific article

Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEUINT.2007.07.014
P932PMC publication ID2904528
P698PubMed publication ID17767979
P5875ResearchGate publication ID6072514

P2093author name stringPatricia H Reggio
Margaret E Rice
Zsuzsanna Sidló
P2860cites workCannabinoid receptor localization in brainQ24558751
Identification and functional characterization of brainstem cannabinoid CB2 receptorsQ28276972
Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neuronsQ28363375
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic studyQ29615905
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.Q46384445
Endocannabinoids restrict hippocampal long-term potentiation via CB1.Q46540624
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study.Q47242856
Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitroQ48127886
A possible role of nitric oxide in the regulation of dopamine transporter function in the striatumQ48183874
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.Q48217036
Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.Q48452719
Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic miceQ48477201
Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum.Q48522731
Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.Q48631827
Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetryQ49101650
An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.Q51139556
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.Q51976878
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.Q52030475
Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitroQ61169045
Activational role of cannabinoids on movementQ73575705
Improved methods for construction of carbon fibre electrodes for extracellular spike recordingQ74531919
The functional anatomy of basal ganglia disordersQ29617461
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brainQ30047898
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatumQ31817073
Etiology and pathogenesis of Parkinson's diseaseQ33593402
Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous systemQ33852893
Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.Q33965686
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatumQ34102291
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptorQ34159367
Nitric oxide: a novel link between synaptic and nonsynaptic transmissionQ34183621
Putting a spin on the dorsal-ventral divide of the striatum.Q34335471
Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptomsQ34349067
Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover studyQ34358022
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.Q34602111
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatumQ34605794
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disordersQ35586641
Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine releaseQ36161572
H2O2 signaling in the nigrostriatal dopamine pathway via ATP-sensitive potassium channels: issues and answers.Q36658164
Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neuronsQ42450378
Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptorQ42466056
Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in ratsQ42469510
Synaptic localization of GABA(A) receptor subunits in the striatum of the rat.Q42480628
Subcellular localization of type 1 cannabinoid receptors in the rat basal gangliaQ42486484
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease modelsQ42508054
Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in miceQ42554293
Biphasic effects of anandamideQ43332781
Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.Q43744889
Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo.Q43805334
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot studyQ43820144
Postsynaptic endocannabinoid release is critical to long-term depression in the striatumQ43971441
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibersQ44169935
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's diseaseQ44285779
Catalepsy induced by intrastriatal injections of Δ9-THC and 11-OH-Δ9-THC in the ratQ44293969
Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.Q44396234
Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal gangliaQ44451116
Neuromorphological background of cannabis addictionQ44494962
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesiasQ44597458
Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake.Q44681104
Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.Q44770106
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.Q44885114
Frequency-dependent modulation of dopamine release by nicotineQ44898075
Nicotine amplifies reward-related dopamine signals in striatumQ44898077
Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptorsQ44928807
Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat.Q45119266
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.Q46279749
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectstriatumQ1319792
P304page(s)80-88
P577publication date2007-07-22
P1433published inNeurochemistry InternationalQ7002160
P1476titleInhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels
P478volume52